Welcome to our dedicated page for Strive SEC filings (Ticker: ASST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Strive, Inc. filings document the company’s structured finance and asset management business, bitcoin treasury operations, preferred stock structure, and public-company governance. Its 8-K reports disclose business updates such as bitcoin, cash, investment and capital stock balances, dividend actions for the Variable Rate Series A Perpetual Preferred Stock, and quarterly operating and financial results.
Strive’s SEC record also includes proxy materials for annual meeting matters, including auditor ratification, and disclosures identifying the company as a Nevada corporation and emerging growth company. Filing subjects include Class A and Class B common stock, SATA preferred stock, advisory activities through Strive Asset Management, LLC, forward-looking risk language, and material-event reporting tied to capital allocation and treasury strategy.
Strive, Inc. furnished an 8‑K to announce that it issued a press release with financial results for the quarter ended September 30, 2025. The press release is included as Exhibit 99.1 and dated November 14, 2025.
The company states the Item 2.02 information, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act or incorporated by reference except as expressly provided. The report was signed by Chief Executive Officer Matthew Cole.
Strive, Inc. reposted a communication on X from board member Pierre Rochard regarding its proposed business combination with Semler Scientific (SMLR). The notice reiterates forward‑looking statement cautions and points investors to SEC filings for details.
Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication also outlines where to access the S-4, related amendments, and future materials, and clarifies that this is not an offer to sell or solicit securities.
Strive, Inc. released a communication under Rule 425 about its proposed business combination with Semler Scientific, Inc. (SMLR). The message includes a broad forward‑looking statements disclaimer highlighting uncertainties around timing, integration and expected strategic and financial benefits.
Strive has filed a Registration Statement on Form S‑4 that will include an information statement of Strive, a proxy statement of Semler Scientific and a prospectus of Strive. Semler Scientific stockholders will receive a definitive document to vote on the transaction, and investors are urged to read the Registration Statement and related materials when available on the SEC’s website. The communication also states it is not an offer or solicitation to sell securities.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The companies emphasize forward-looking statement cautions, outline where investors can access SEC filings, note that directors and officers may be participants in the proxy solicitation, and clarify that this communication is not an offer or solicitation.
Strive, Inc. reposted on X a communication about its proposed business combination with Semler Scientific (SMLR). The message includes a forward‑looking statements caution and notes that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval, and investors are urged to read these materials when available. Documents will be accessible free of charge on the SEC’s website and via company investor relations pages. The communication also states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific (SMLR), noting that CEO Matthew Cole reposted the communication on X.com on November 12, 2025.
Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in connection with the transaction. The S-4 will include an information statement/proxy statement/prospectus, and a definitive version will be sent to Semler stockholders to seek approval of the proposed transaction.
The notice includes extensive forward‑looking statement disclaimers and directs investors to read the S-4 and related materials when available, which will be accessible free of charge on the SEC’s website and the companies’ investor sites.
Strive, Inc. announced a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement/proxy statement/prospectus. Semler Scientific stockholders will receive definitive materials to vote on the proposed transaction.
The notice includes a forward-looking statements caution, identifies potential proxy solicitation participants, and clarifies this is not an offer or solicitation. Related documents will be available free of charge at SEC.gov and the companies’ investor relations websites.
Strive, Inc. filed a Rule 425 communication about its proposed business combination with Semler Scientific (SMLR). The notice reiterates standard forward‑looking statement cautions and directs investors to SEC filings for details.
Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, with related Information Statement/Proxy Statement/Prospectus materials, including versions filed on August 6, 2025 and October 10, 2025. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval of the proposed transaction.
The communication emphasizes that it is not an offer to sell or solicit an offer to buy securities. Investors are urged to read the Registration Statement and related materials when available, accessible free of charge on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Registration Statement on Form S‑4 to register the Class A common stock it would issue in the transaction, which will include an information statement of Strive, a proxy statement for Semler Scientific stockholders, and a prospectus of Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication includes forward‑looking statements subject to risks and uncertainties referenced in prior SEC filings of both companies. It also notes that directors, officers, and certain employees of both companies may be deemed participants in the proxy solicitation.
This notice reiterates that it is not an offer or solicitation to sell or buy securities. Investors are urged to read the S‑4 and related materials when available on the SEC’s website and company investor sites.
Strive, Inc. issued a Rule 425 communication regarding its proposed business combination with Semler Scientific. Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction. The registration will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval.
The communication contains forward-looking statement disclaimers and directs investors to SEC filings for risks and details, including Strive’s S-4 and related reports and Semler Scientific’s 10-K and 10-Qs. It notes that directors and officers of both companies may be deemed participants in the proxy solicitation and provides links to obtain documents free of charge. It also states this is not an offer to sell securities.